Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer

International Journal of Colorectal Disease

Volumn 27, Issue 1, 2012, Pages 31-36

  Zhu, Ming Chen ^a   Xu, Yi Jun ^b   Zou, Xiong ^c   Yan, Feng ^a  

^a JIANGSU CANCER HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Colorectal cancer . Peripheral blood mononuclear cell . HLA A . RT PCR

Indexed keywords

CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HLA A ANTIGEN; MESSENGER RNA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REAL TIME QUANTITATIVE POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR IMMUNITY;

ADULT; AGED; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-A ANTIGENS; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 84857044265     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1315-4     Document Type: Article

References (29)

1. Pasetto LM, D'Andrea MR, Jirillo A et al (2006) Stable disease in advanced colorectal cancer: therapeutic implications. Anticancer Res 26:511-522 (Pubitemid 43210321)
2. Popat S, Zhao D, Chen Z et al (2007) Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients. Anticancer Res 27:627-633 (Pubitemid 46379711)
3. Jemal A, Siegel R, Ward E et al (2006) Cancer statistics. CA Cancer J Clin 56:106-130
4. Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a populationbased study. Cancer 109:718-726 (Pubitemid 46233233)
5. Chen CD, Yen MF, Wang WM et al (2003) A case-cohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. Br J Cancer 88:1866-1873
6. Vermorken JB, Claessen AM, van Tinteren H et al (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353:345-350 (Pubitemid 29088160)
7. Riethmuller G, Schneider Gadicke E, Schlimok G et al (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma. German Cancer Aid 17-1A Study Group. Lancet 343:1177-1183 (Pubitemid 24147551)
8. Moertel CG, Fleming TR, Macdonald JS et al (1990) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322:352-358 (Pubitemid 20042739)
9. Moller P, Koretz K, Schlag P et al (1991) Frequency of abnormal expression of HLA-A, B, C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence. Int J Cancer Suppl 6:155-162
10. Momburg F, Degener T, Bacchus E et al (1986) Loss of HLA-A, B, C and de novo expression of HLA-D in colorectal cancer. Int J Cancer 37:179-184 (Pubitemid 16152439)
11. McDougall CJ, Ngoi SS, Goldman IS et al (1990) Reduced expression of HLA class I and II antigens in colon cancer. Cancer Res 50:8023-8027
12. Cordon CC, Fuks Z, Drobnjak M et al (1991) Expression of HLAA, B, C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res 51:6372-6380
13. Ruiz CF, Lopez-Nevot MA, Gutierrez J et al (1989) Phenotypic expression of histocompatibility antigens in human primary tumours and metastases. Clin Exp Metastasis 7:213-226 (Pubitemid 19071385)
14. Lopez-Nevot MA, Esteban F, Ferron A et al (1989) HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 59:221-226 (Pubitemid 19072721)
15. Garrido F, Algarra I (2001) MHC antigens and tumor escape from immune surveillance. Adv Cancer Res 83:117-158 (Pubitemid 32959264)
16. Seliger B, Cabrera T, Garrido F et al (2002) HLA class I antigen abnormalities and immune escape by malignant cells. Semin Cancer Biol 12:3-13 (Pubitemid 34087893)
17. Menon AG, Janssen-van Rhijn CM, Morreau H et al (2004) Immune system and prognosis in colorectal cancer: a detailed immunohistochemical analysis. Lab Invest 84:493-501 (Pubitemid 41656477)
18. Miyagi T, Tatsumi T, Takehara T et al (2003) Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells. J Gastroenterol Hepatol 18:32-40 (Pubitemid 36062584)
19. Le Morvan C, Cogne M, Drouet M (2001) HLA-A and HLA-B transcription decrease with ageing in peripheral blood leucocytes. Clin Exp Immunol 125:245-250 (Pubitemid 32758435)
20. Le Morvan C, Cogne M, Drouet M (2001) An elevation in the concentration of HLA class I molecules in human blood due to ageing. Mech Ageing Dev 122:335-340 (Pubitemid 32322448)
21. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(?Delta Delta C(T)) method. Methods: 25:402-408 (Pubitemid 34164012)
22. Bernards R, Dessain SK, Weinberg RA (1986) N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47:667-674 (Pubitemid 17011410)
23. Versteeg R, van der Minne C, Plomp A et al (1990) N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells. Mol Cell Biol 10:5416-5423
24. Cheng NC, Beitsma M, Chan A et al (1996) Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus. Oncogene 13:1737-1744 (Pubitemid 26377506)
25. Gross N, Beck D, Favre S (1990) In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells. Cancer Res 50:7532-7536
26. Jass JR, Baker K, Zlobec I et al (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49:121-131 (Pubitemid 44079695)
27. Chan TL, Zhao W, Leung SY, et al (2003) Cancer Genome Project. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63:4878-4881 (Pubitemid 37022620)
28. Torlakovic E, Skovlund E, Snover DC et al (2003) Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27:65-81 (Pubitemid 36014900)
29. Goldstein NS, Bhanot P, Odish E et al (2003) Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol 119:778-796 (Pubitemid 37047838)